WallStreetZen

NASDAQ: AZN
Astrazeneca Plc Earnings & Revenue

AZN past earnings growth

How has AZN's earnings growth performed historically?
Company
18.01%
Industry
12.52%
Market
38.18%
AZN's earnings have grown faster (7.07% per year) than the US Drug Manufacturers - General industry average (6.08%)
Performance
AZN's earnings have grown slower (7.07% per year) than the US market average (28.61%)
Performance
AZN's earnings growth is accelerating - its growth over the last year (18.01%) is above its 5-year compound annual rate (7.07%)
Performance

AZN past revenue growth

How has AZN's revenue growth performed historically?
Company
7.18%
Industry
8.9%
Market
16%
AZN's revenue has grown slower (0.67% per year) than the US Drug Manufacturers - General industry average (4.25%)
Performance
AZN's revenue has grown slower (0.67% per year) than the US market average (16.19%)
Performance
AZN's revenue growth is accelerating - its growth over the last year (7.18%) is above its 5-year compound annual rate (0.67%)
Performance

AZN earnings and revenue history

Current Revenue
$25.9B
Current Earnings
$2.4B
Current Profit Margin
9.3%
AZN's has not demonstrated consistent long-term earnings growth over the past 10 years (-65.58%)
Performance

AZN Return on equity

Current Company
20%
Current Industry
55.3%
Current Market
23.9%
AZN's Return on Equity (20%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

AZN Return on assets

Current Company
4%
Current Industry
8.6%
Current Market
6.2%
AZN is generating lower Return on Assets (4%) than the US Drug Manufacturers - General industry average (8.23%)
Performance

AZN Return on capital employed

Current Company
9.57%
Current Industry
12.8%
AZN's ability to generate Return on Capital (9.57%) has decreased compared to 3 years ago (11.11%)
Performance

Astrazeneca Earnings & Revenue FAQ

What were AZN's earnings last quarter?

Astrazeneca (NASDAQ: AZN) reported Q3 2020 earnings per share (EPS) of $0.25, up 113.04% year over year. Total Astrazeneca earnings for the quarter were $651.00 million. In the same quarter last year, Astrazeneca's earnings per share (EPS) was $0.12.

What was AZN's revenue last quarter?

Astrazeneca (NASDAQ: AZN) reported Q3 2020 revenue of $6.58 billion up 2.68% year over year. In the same quarter last year, Astrazeneca's revenue was $6.41 billion.

What was AZN's earnings growth in the past year?

As of Q1 2021, Astrazeneca's earnings has grown 18.01% year over year. This is 5.49 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 12.52%. Astrazeneca's earnings in the past year totalled $2.42 billion.

What was AZN's revenue growth in the past year?

As of Q1 2021, Astrazeneca's revenue has grown 7.18% year over year. This is 1.72 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 8.9%. Astrazeneca's revenue in the past year totalled $25.87 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics